▶ 調査レポート

複合甘草のグローバル市場2022-2028:錠剤、混合物、その他

• 英文タイトル:Global Compound Liquorice Market Growth 2022-2028

LP Informationが調査・発行した産業分析レポートです。複合甘草のグローバル市場2022-2028:錠剤、混合物、その他 / Global Compound Liquorice Market Growth 2022-2028 / MRC22NVL18953資料のイメージです。• レポートコード:MRC22NVL18953
• 出版社/出版日:LP Information / 2022年10月
• レポート形態:英文、PDF、102ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥541,680 (USD3,660)▷ お問い合わせ
  Corporate User¥1,083,360 (USD7,320)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
世界経済が回復するにつれて、2021年の複合甘草の成長は前年から大幅に変化します。LP Information社(米国)の最新の調査によると、世界の複合甘草市場規模は、2021年の000ドルから2022年には000ドルに達し、2021年~2022年間に000%の成長が予想されます。2028年には世界の複合甘草市場規模が000ドルまで成長し、調査期間中に000%の年平均成長率を記録すると予想されます。
米国の複合甘草市場は2021年に000ドルの市場規模が見込まれ、調査期間中は約000%の年平均成長率で成長すると予測されます。中国は世界の複合甘草市場の000%のシェアを占め、2028年までに000ドルに達すると展望されます。欧州の複合甘草の状況については、ドイツが2028年までに000ドルに達し、調査期間にわたって年平均成長率が000%になると予測されます。アジア地域では、日本と韓国の成長率が、今後5年間でそれぞれ000%と000%になると展望されます。

世界の主要な複合甘草プレーヤーとして、Inner Mongolia Lantai Pharmaceutical、 Tianjin Lisheng Pharmaceutical、 Tianjin Huajin Pharmaceutical Factory、 Beijing Shuanghe Pharmaceutical、 Tongji Hall、 Sinopharm Weiqida Pharmaceutical、 Harbin Taihua Pharmaceutical、 Xiuzheng Pharmaceutical Group、 Jiangxi Tianshikang、 Sichuan Emeishan Pharmaceutical、 Guizhou Yibai Pharmaceutical、 Zhonglian Pharmaceuなどをカバーしています。売上の面では、世界のトップ2社が2021年に約000%市場シェアを占めています。

当レポートでは、製品タイプ、用途(アプリケーション)、主要メーカー、主要地域および国ごとの複合甘草市場の包括的な概要、市場シェア、および成長機会を掲載します。

タイプ別のセグメンテーション:2017年~2022年までの内訳データと2028年まで予測データ
錠剤、混合物、その他

用途(アプリケーション)別のセグメンテーション:2017年~2022年までの内訳データと2028年まで予測データ
病院薬局、小売薬局、オンライン薬局

当レポートは次の地域と国の市場規模データを掲載します。
南北アメリカ(米国、カナダ、メキシコ、ブラジル)
アジア太平洋(中国、日本、韓国、東南アジア、インド、オーストラリア)
欧州(ドイツ、フランス、イギリス、イタリア、ロシア)
中東/アフリカ(エジプト、南アフリカ、イスラエル、トルコ、GCC諸国)

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要:複合甘草の年間販売量2017-2028、地域別現状・将来分析
・複合甘草のタイプ別セグメント:錠剤、混合物、その他
・複合甘草のタイプ別販売量:2017-2022年の販売量、売上、市場シェア、販売価格
・複合甘草の用途別セグメント:病院薬局、小売薬局、オンライン薬局
・複合甘草の用途別販売量:2017-2022年の販売量、売上、市場シェア、販売価格

企業別世界の複合甘草市場
・企業別のグローバル複合甘草市場データ:2020-2022年の年間販売量、市場シェア
・企業別の複合甘草の年間売上:2020-2022年の売上、市場シェア
・企業別の複合甘草販売価格
・主要企業の複合甘草生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

複合甘草の地域別レビュー
・地域別の複合甘草市場規模2017-2022:年間販売量、売上
・主要国別の複合甘草市場規模2017-2022:年間販売量、売上
・南北アメリカの複合甘草販売の成長
・アジア太平洋の複合甘草販売の成長
・欧州の複合甘草販売の成長
・中東・アフリカの複合甘草販売の成長

南北アメリカ市場
・南北アメリカの国別の複合甘草販売量、売上(2017-2022)
・南北アメリカの複合甘草の種類別販売量
・南北アメリカの複合甘草の用途別販売量
・米国の複合甘草市場
・カナダの複合甘草市場
・メキシコの複合甘草市場
・ブラジルの複合甘草市場

アジア太平洋市場
・アジア太平洋の国別の複合甘草販売量、売上(2017-2022)
・アジア太平洋の複合甘草の種類別販売量
・アジア太平洋の複合甘草の用途別販売量
・中国市場の複合甘草市場
・日本市場の複合甘草市場
・韓国市場の複合甘草市場
・東南アジアの複合甘草市場
・インドの複合甘草市場
・オーストラリアの複合甘草市場
・台湾の複合甘草市場

欧州市場
・欧州の国別の複合甘草販売量、売上(2017-2022)
・欧州の複合甘草の種類別販売量
・欧州の複合甘草の用途別販売量
・ドイツの複合甘草市場
・フランスの複合甘草市場
・イギリスの複合甘草市場
・イタリアの複合甘草市場
・ロシアの複合甘草市場

中東・アフリカ市場
・中東・アフリカの国別の複合甘草販売量、売上(2017-2022)
・中東・アフリカの複合甘草の種類別販売量
・中東・アフリカの複合甘草の用途別販売量
・エジプトの複合甘草市場
・南アフリカの複合甘草市場
・イスラエルの複合甘草市場
・トルコの複合甘草市場
・GCC諸国の複合甘草市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・複合甘草の製造コスト構造分析
・複合甘草の製造プロセス分析
・複合甘草の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル:直接販売チャンネル、間接販売チャンネル
・複合甘草の主要なグローバル販売業者
・複合甘草の主要なグローバル顧客

地域別の複合甘草市場予測レビュー
・地域別の複合甘草市場規模予測(2023-2028)
・南北アメリカの国別予測
・アジア太平洋の国別予測
・欧州の国別予測
・複合甘草のタイプ別市場規模予測
・複合甘草の用途別市場規模予測

主要企業分析
Inner Mongolia Lantai Pharmaceutical、 Tianjin Lisheng Pharmaceutical、 Tianjin Huajin Pharmaceutical Factory、 Beijing Shuanghe Pharmaceutical、 Tongji Hall、 Sinopharm Weiqida Pharmaceutical、 Harbin Taihua Pharmaceutical、 Xiuzheng Pharmaceutical Group、 Jiangxi Tianshikang、 Sichuan Emeishan Pharmaceutical、 Guizhou Yibai Pharmaceutical、 Zhonglian Pharmaceu
・企業情報
・複合甘草製品
・複合甘草販売量、売上、価格、粗利益(2020-2022)
・主要ビジネス概要
・最新動向

調査結果および結論

As the global economy mends, the 2021 growth of Compound Liquorice will have significant change from previous year. According to our (LP Information) latest study, the global Compound Liquorice market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Compound Liquorice market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Compound Liquorice market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Compound Liquorice market, reaching US$ million by the year 2028. As for the Europe Compound Liquorice landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Compound Liquorice players cover Inner Mongolia Lantai Pharmaceutical, Tianjin Lisheng Pharmaceutical, Tianjin Huajin Pharmaceutical Factory, and Beijing Shuanghe Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Compound Liquorice market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Tablets
Mixtures
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Inner Mongolia Lantai Pharmaceutical
Tianjin Lisheng Pharmaceutical
Tianjin Huajin Pharmaceutical Factory
Beijing Shuanghe Pharmaceutical
Tongji Hall
Sinopharm Weiqida Pharmaceutical
Harbin Taihua Pharmaceutical
Xiuzheng Pharmaceutical Group
Jiangxi Tianshikang
Sichuan Emeishan Pharmaceutical
Guizhou Yibai Pharmaceutical
Zhonglian Pharmaceutical
Guangxi Nanning Baihui Pharmaceutical
Tsumura & Co.

レポート目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Compound Liquorice Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Compound Liquorice by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Compound Liquorice by Country/Region, 2017, 2022 & 2028
2.2 Compound Liquorice Segment by Type
2.2.1 Tablets
2.2.2 Mixtures
2.2.3 Other
2.3 Compound Liquorice Sales by Type
2.3.1 Global Compound Liquorice Sales Market Share by Type (2017-2022)
2.3.2 Global Compound Liquorice Revenue and Market Share by Type (2017-2022)
2.3.3 Global Compound Liquorice Sale Price by Type (2017-2022)
2.4 Compound Liquorice Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Compound Liquorice Sales by Application
2.5.1 Global Compound Liquorice Sale Market Share by Application (2017-2022)
2.5.2 Global Compound Liquorice Revenue and Market Share by Application (2017-2022)
2.5.3 Global Compound Liquorice Sale Price by Application (2017-2022)
3 Global Compound Liquorice by Company
3.1 Global Compound Liquorice Breakdown Data by Company
3.1.1 Global Compound Liquorice Annual Sales by Company (2020-2022)
3.1.2 Global Compound Liquorice Sales Market Share by Company (2020-2022)
3.2 Global Compound Liquorice Annual Revenue by Company (2020-2022)
3.2.1 Global Compound Liquorice Revenue by Company (2020-2022)
3.2.2 Global Compound Liquorice Revenue Market Share by Company (2020-2022)
3.3 Global Compound Liquorice Sale Price by Company
3.4 Key Manufacturers Compound Liquorice Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Compound Liquorice Product Location Distribution
3.4.2 Players Compound Liquorice Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Compound Liquorice by Geographic Region
4.1 World Historic Compound Liquorice Market Size by Geographic Region (2017-2022)
4.1.1 Global Compound Liquorice Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Compound Liquorice Annual Revenue by Geographic Region
4.2 World Historic Compound Liquorice Market Size by Country/Region (2017-2022)
4.2.1 Global Compound Liquorice Annual Sales by Country/Region (2017-2022)
4.2.2 Global Compound Liquorice Annual Revenue by Country/Region
4.3 Americas Compound Liquorice Sales Growth
4.4 APAC Compound Liquorice Sales Growth
4.5 Europe Compound Liquorice Sales Growth
4.6 Middle East & Africa Compound Liquorice Sales Growth
5 Americas
5.1 Americas Compound Liquorice Sales by Country
5.1.1 Americas Compound Liquorice Sales by Country (2017-2022)
5.1.2 Americas Compound Liquorice Revenue by Country (2017-2022)
5.2 Americas Compound Liquorice Sales by Type
5.3 Americas Compound Liquorice Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Compound Liquorice Sales by Region
6.1.1 APAC Compound Liquorice Sales by Region (2017-2022)
6.1.2 APAC Compound Liquorice Revenue by Region (2017-2022)
6.2 APAC Compound Liquorice Sales by Type
6.3 APAC Compound Liquorice Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Compound Liquorice by Country
7.1.1 Europe Compound Liquorice Sales by Country (2017-2022)
7.1.2 Europe Compound Liquorice Revenue by Country (2017-2022)
7.2 Europe Compound Liquorice Sales by Type
7.3 Europe Compound Liquorice Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Compound Liquorice by Country
8.1.1 Middle East & Africa Compound Liquorice Sales by Country (2017-2022)
8.1.2 Middle East & Africa Compound Liquorice Revenue by Country (2017-2022)
8.2 Middle East & Africa Compound Liquorice Sales by Type
8.3 Middle East & Africa Compound Liquorice Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Compound Liquorice
10.3 Manufacturing Process Analysis of Compound Liquorice
10.4 Industry Chain Structure of Compound Liquorice
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Compound Liquorice Distributors
11.3 Compound Liquorice Customer
12 World Forecast Review for Compound Liquorice by Geographic Region
12.1 Global Compound Liquorice Market Size Forecast by Region
12.1.1 Global Compound Liquorice Forecast by Region (2023-2028)
12.1.2 Global Compound Liquorice Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Compound Liquorice Forecast by Type
12.7 Global Compound Liquorice Forecast by Application
13 Key Players Analysis
13.1 Inner Mongolia Lantai Pharmaceutical
13.1.1 Inner Mongolia Lantai Pharmaceutical Company Information
13.1.2 Inner Mongolia Lantai Pharmaceutical Compound Liquorice Product Offered
13.1.3 Inner Mongolia Lantai Pharmaceutical Compound Liquorice Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Inner Mongolia Lantai Pharmaceutical Main Business Overview
13.1.5 Inner Mongolia Lantai Pharmaceutical Latest Developments
13.2 Tianjin Lisheng Pharmaceutical
13.2.1 Tianjin Lisheng Pharmaceutical Company Information
13.2.2 Tianjin Lisheng Pharmaceutical Compound Liquorice Product Offered
13.2.3 Tianjin Lisheng Pharmaceutical Compound Liquorice Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Tianjin Lisheng Pharmaceutical Main Business Overview
13.2.5 Tianjin Lisheng Pharmaceutical Latest Developments
13.3 Tianjin Huajin Pharmaceutical Factory
13.3.1 Tianjin Huajin Pharmaceutical Factory Company Information
13.3.2 Tianjin Huajin Pharmaceutical Factory Compound Liquorice Product Offered
13.3.3 Tianjin Huajin Pharmaceutical Factory Compound Liquorice Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Tianjin Huajin Pharmaceutical Factory Main Business Overview
13.3.5 Tianjin Huajin Pharmaceutical Factory Latest Developments
13.4 Beijing Shuanghe Pharmaceutical
13.4.1 Beijing Shuanghe Pharmaceutical Company Information
13.4.2 Beijing Shuanghe Pharmaceutical Compound Liquorice Product Offered
13.4.3 Beijing Shuanghe Pharmaceutical Compound Liquorice Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Beijing Shuanghe Pharmaceutical Main Business Overview
13.4.5 Beijing Shuanghe Pharmaceutical Latest Developments
13.5 Tongji Hall
13.5.1 Tongji Hall Company Information
13.5.2 Tongji Hall Compound Liquorice Product Offered
13.5.3 Tongji Hall Compound Liquorice Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Tongji Hall Main Business Overview
13.5.5 Tongji Hall Latest Developments
13.6 Sinopharm Weiqida Pharmaceutical
13.6.1 Sinopharm Weiqida Pharmaceutical Company Information
13.6.2 Sinopharm Weiqida Pharmaceutical Compound Liquorice Product Offered
13.6.3 Sinopharm Weiqida Pharmaceutical Compound Liquorice Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Sinopharm Weiqida Pharmaceutical Main Business Overview
13.6.5 Sinopharm Weiqida Pharmaceutical Latest Developments
13.7 Harbin Taihua Pharmaceutical
13.7.1 Harbin Taihua Pharmaceutical Company Information
13.7.2 Harbin Taihua Pharmaceutical Compound Liquorice Product Offered
13.7.3 Harbin Taihua Pharmaceutical Compound Liquorice Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Harbin Taihua Pharmaceutical Main Business Overview
13.7.5 Harbin Taihua Pharmaceutical Latest Developments
13.8 Xiuzheng Pharmaceutical Group
13.8.1 Xiuzheng Pharmaceutical Group Company Information
13.8.2 Xiuzheng Pharmaceutical Group Compound Liquorice Product Offered
13.8.3 Xiuzheng Pharmaceutical Group Compound Liquorice Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Xiuzheng Pharmaceutical Group Main Business Overview
13.8.5 Xiuzheng Pharmaceutical Group Latest Developments
13.9 Jiangxi Tianshikang
13.9.1 Jiangxi Tianshikang Company Information
13.9.2 Jiangxi Tianshikang Compound Liquorice Product Offered
13.9.3 Jiangxi Tianshikang Compound Liquorice Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Jiangxi Tianshikang Main Business Overview
13.9.5 Jiangxi Tianshikang Latest Developments
13.10 Sichuan Emeishan Pharmaceutical
13.10.1 Sichuan Emeishan Pharmaceutical Company Information
13.10.2 Sichuan Emeishan Pharmaceutical Compound Liquorice Product Offered
13.10.3 Sichuan Emeishan Pharmaceutical Compound Liquorice Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Sichuan Emeishan Pharmaceutical Main Business Overview
13.10.5 Sichuan Emeishan Pharmaceutical Latest Developments
13.11 Guizhou Yibai Pharmaceutical
13.11.1 Guizhou Yibai Pharmaceutical Company Information
13.11.2 Guizhou Yibai Pharmaceutical Compound Liquorice Product Offered
13.11.3 Guizhou Yibai Pharmaceutical Compound Liquorice Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Guizhou Yibai Pharmaceutical Main Business Overview
13.11.5 Guizhou Yibai Pharmaceutical Latest Developments
13.12 Zhonglian Pharmaceutical
13.12.1 Zhonglian Pharmaceutical Company Information
13.12.2 Zhonglian Pharmaceutical Compound Liquorice Product Offered
13.12.3 Zhonglian Pharmaceutical Compound Liquorice Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Zhonglian Pharmaceutical Main Business Overview
13.12.5 Zhonglian Pharmaceutical Latest Developments
13.13 Guangxi Nanning Baihui Pharmaceutical
13.13.1 Guangxi Nanning Baihui Pharmaceutical Company Information
13.13.2 Guangxi Nanning Baihui Pharmaceutical Compound Liquorice Product Offered
13.13.3 Guangxi Nanning Baihui Pharmaceutical Compound Liquorice Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Guangxi Nanning Baihui Pharmaceutical Main Business Overview
13.13.5 Guangxi Nanning Baihui Pharmaceutical Latest Developments
13.14 Tsumura & Co.
13.14.1 Tsumura & Co. Company Information
13.14.2 Tsumura & Co. Compound Liquorice Product Offered
13.14.3 Tsumura & Co. Compound Liquorice Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Tsumura & Co. Main Business Overview
13.14.5 Tsumura & Co. Latest Developments
14 Research Findings and Conclusion